2021
DOI: 10.1016/j.crad.2021.03.014
|View full text |Cite
|
Sign up to set email alerts
|

Risk of acute pulmonary embolism in COVID-19 pneumonia compared to community-acquired pneumonia: a retrospective case–control study

Abstract: Aim To compare the incidence of pulmonary embolism (PE) in COVID-19 pneumonia and non-COVID-19-related community-acquired pneumonia (CAP) in hospitalised patients. Materials and methods A retrospective case–control study was conducted. This included patients hospitalised with pneumonia and investigated for suspected PE with computed tomography pulmonary angiogram (CTPA). Cases were defined as patients with COVID-19 pneumonia from 1 March 2020 to 17 May 2020; controls we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 29 publications
0
1
0
Order By: Relevance
“…This is in line with previous comparisons between patients with COVID-19 and sepsis, 32 , 33 although other studies reported increased D-dimer in COVID-19 when compared with other CAPs. 34 , 35 Together, our data may indicate that high PAI-1 levels could limit fibrin degradation and subsequent D-dimer release, resulting in relatively low D-dimer levels in COVID-19.…”
Section: Discussionmentioning
confidence: 70%
“…This is in line with previous comparisons between patients with COVID-19 and sepsis, 32 , 33 although other studies reported increased D-dimer in COVID-19 when compared with other CAPs. 34 , 35 Together, our data may indicate that high PAI-1 levels could limit fibrin degradation and subsequent D-dimer release, resulting in relatively low D-dimer levels in COVID-19.…”
Section: Discussionmentioning
confidence: 70%
“…The study period in this cohort may have been the factor leading to this finding. The study is conducted at a time when several COVID-19-related studies are published, demonstrating that patients with COVID-19 infections are at increased risk of developing thrombosis [27][28][29]. We postulate that these studies may have influenced treating physicians to proceed with CTPA even though there is a lack of clinical evidence suggesting PE, lowering the odds of positive results in these CTPAs.…”
Section: Discussionmentioning
confidence: 99%